Anna Ofverholm
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Making patient-oriented decisions with collegial support as an anchor: Oncologists' experiences of late-line treatment selection in metastatic breast cancer.
Journal: Patient education and counseling
Published: March 28, 2026
"Choosing the main character": healthcare professionals' attitudes towards counselling patients about risk disclosure to relatives in the era of mainstream cancer genetic testing.
Journal: Familial cancer
Published: September 07, 2025
Direct letters to relatives at risk of hereditary cancer-a randomised trial on healthcare-assisted versus family-mediated risk disclosure.
Journal: European journal of human genetics : EJHG
Published: February 24, 2025
The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer.
The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer.
Journal: European journal of human genetics : EJHG
Published: July 02, 2023
Public support for healthcare-mediated disclosure of hereditary cancer risk information: Results from a population-based survey in Sweden.
Journal: Hereditary cancer in clinical practice
Published: October 09, 2019
Re: Peter Ström, Tobias Nordström, Henrik Grönberg, Martin Eklund. The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.12.028.
Journal: European urology
Published: January 30, 2018
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
Journal: Human mutation
Published: October 30, 2017
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
Journal: Journal of the National Cancer Institute
Published: March 30, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026